Maintenance Treatment and Survival in Patients With Myeloma

医学 多发性骨髓瘤 危险系数 荟萃分析 内科学 随机对照试验 养生 肿瘤科 置信区间
作者
Francesca Gay,Graham Jackson,Laura Rosiñol,Sarah A. Holstein,Philippe Moreau,Stefano Spada,Faith E. Davies,Juan José Lahuerta,Xavier Leleu,Sara Bringhen,Andrea Evangelista,Cyrille Hulin,Ugo Panzani,David A. Cairns,Francesco Di Raimondo,Margaret Macro,Anna Marina Liberati,Charlotte Pawlyn,Massimo Offidani,Andrew Spencer
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:4 (10): 1389-1389 被引量:83
标识
DOI:10.1001/jamaoncol.2018.2961
摘要

Importance

Several trials demonstrated the impact of novel agent-based maintenance in newly diagnosed multiple myeloma (NDMM), but there is no current evidence demonstrating the superiority of one regimen over the other, owing to the lack of direct/indirect comparisons.

Objective

To analyze and compare the effectiveness of different maintenance regimens in NDMM via a network meta-analysis.

Data Sources

We performed 2 independent searches in PubMed and Cochrane databases, and then we identified all the records registered after 1999 and on or before November 20, 2017.

Study Selection

By blinded review, we identified prospective phase 3 randomized trials evaluating novel agent-based maintenance in patients with NDMM; the included studies compared at least 2 maintenance approaches; comparators included placebo and no maintenance. From 364 screened records, 11 studies were included.

Data Extraction and Synthesis

We followed (independent extraction) the guidelines provided by the PRISMA Report and the EQUATOR Network. The evidence was synthesized using a network meta-analysis (NMA). To allow comparison of all treatments, no maintenance was selected as common comparator and the effect of placebo was assumed to be the same as no treatment. The best option was identified by a Bayesian consistency model based on hazard ratio (HR), 95% credible interval (CrI), probability of being the best treatment (PbBT), and median ranking distribution (MedR).

Main Outcomes and Measures

Outcomes of interest were progression-free survival (PFS) and overall survival (OS).

Results

Eleven trials and 8 treatments including a total of 5073 participants were included. By PFS analysis, lenalidomide-based regimens (lenalidomide-prednisone, lenalidomide alone) were identified as the most effective options (HR, 0.39 [95% CrI, 0.28-0.53] and 0.47 [95% CrI, 0.39-0.55], respectively; MedR, 1 and 2; overall PbBT, 74%). Four treatments (thalidomide-interferon, thalidomide-bortezomib, bortezomib-prednisone, thalidomide alone) showed an HR in favor of maintenance. By OS analysis, lenalidomide alone was identified as the best option (HR, 0.76; 95% CrI, 0.51-1.16; MedR, 2; PbBT, 38%), followed by bortezomib-thalidomide and bortezomib-prednisone. Similar features were noticed in the restricted network including transplant trials, in the sensitivity analysis, and in most of the prognostic subgroups.

Conclusions and Relevance

Based on PFS and OS results of this NMA, lenalidomide maintenance appears to be the best treatment option, by synthesizing the available evidence of novel agent-based maintenance in the past 20 years.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
排列组合式文章完成签到,获得积分10
刚刚
情怀的应助被aaairplane采纳,获得10
1秒前
充电宝的应助被木木采纳,获得10
1秒前
JJKK发布了新的文献求助10
1秒前
1秒前
2秒前
简单澜发布了新的文献求助10
3秒前
3秒前
3秒前
vv发布了新的文献求助30
4秒前
搜集达人的应助被moment采纳,获得10
4秒前
斯文败类的应助被苯环采纳,获得10
4秒前
乔文达完成签到,获得积分10
4秒前
5秒前
彭铭渌发布了新的文献求助10
5秒前
one发布了新的文献求助10
5秒前
宫傲蕾完成签到 ,获得积分10
5秒前
迷人怜翠发布了新的文献求助10
6秒前
洁净芹发布了新的文献求助10
6秒前
6秒前
7秒前
trison完成签到,获得积分10
8秒前
有魅力的臻完成签到,获得积分10
8秒前
8秒前
8秒前
王乐乐发布了新的文献求助10
9秒前
Maestro_S的应助被只做早餐采纳,获得50
10秒前
简单澜完成签到,获得积分10
11秒前
11秒前
酱油发布了新的文献求助10
11秒前
zqz发布了新的文献求助10
12秒前
12秒前
斯文败类的应助被muzili采纳,获得10
12秒前
12秒前
12秒前
南楠完成签到,获得积分10
13秒前
兴奋雪珍发布了新的文献求助10
13秒前
FashionBoy的应助被火山采纳,获得10
13秒前
妮妮发布了新的文献求助10
13秒前
遇见完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192141
求助须知:如何正确求助?哪些是违规求助? 9578771
关于积分的说明 21861764
捐赠科研通 7791657
什么是DOI,文献DOI怎么找? 3436846
关于科研通互助平台的介绍 2560547
邀请新用户注册赠送积分活动 2483605